Background
Methods
Data source
Outcome
Chronic conditions
Covariates
Statistical analyses
Ethics
Results
Study population
Sample size | Age | ||||
---|---|---|---|---|---|
N | %a | (mean,σ) | N | rateb [95 % CI] | |
All women | 4226 | 100 | 44,6 (11,0) | 3201 | 75,8 [74,5-77,2] |
Inflammatory systemic diseasec | 98 | 2,4 | 48,9 (10,8) | 66 | 72,5 [63,8-81,2] |
Cancerd | 122 | 3,0 | 52,3 (9,2) | 98 | 80,1 [69,3-91,0] |
Cardiovascular disease | 87 | 2,1 | 51,7 (9,5) | 59 | 74,0 [64,7-83,2] |
Chronic Respiratory disease | 294 | 7,2 | 45,4 (11,4) | 199 | 67,7 [62,3-73,2] |
Depressione | 177 | 4,7 | 46,7 (10,3) | 137 | 76,3 [69,3-83,4] |
Diabetes | 122 | 2,9 | 54,1 (8,0) | 67 | 63,6 [51,3-76,0] |
Dyslipidemiae | 167 | 4,1 | 55,0 (7,4) | 117 | 74,7 [63,9-85,5] |
Hypertensione | 331 | 8,1 | 53,7 (8,1) | 228 | 74,5 [68,1-80,9] |
Obesity | 518 | 12,1 | 46,5 (11,2) | 326 | 65,0 [60,7-69,3] |
Osteoarthritis | 653 | 16,0 | 52,4 (8,8) | 465 | 74,1 [69,8-78,3] |
Thyroid disorders | 323 | 7,6 | 48,3 (9,8) | 248 | 77,6 [72,7-82,4] |
Sample size | Age | Overall screening | Organized screening | Opportunistic screening | |||||
---|---|---|---|---|---|---|---|---|---|
N | %a | (mean,σ) | N | rateb [95 % CI] | N | rateb [95 % CI] | N | rateb [95 % CI] | |
All women | 2056 | 100 | 60,2 (7,0) | 1533 | 74,9 [73.0-76.9] | 1091 | 54,4 [52,2-56,6] | 374 | 17,2 [15.6-18.8] |
Inflammatory systemic diseasec | 84 | 4,3 | 62,7 (7,2) | 67 | 79,3 [70,2-88,4] | 50 | 58,3 [47,0-69,5] | 13 | 16,6 [1, 1-8, 8-25] |
Cancerd | 67 | 3,4 | 63,1 (7,0) | 48 | 76,0 [65,8-86,2] | 33 | 51,4 [38,5-64,3] | 11 | 20,1 [9,1-31,0] |
Cardiovascular disease | 96 | 4,9 | 64,0 (7,4) | 69 | 69,7 [59,8-79,7] | 57 | 56,4 [46,7-66,1] | 9 | 10,9 [3,1-18,7] |
Chronic Respiratory disease | 173 | 8,8 | 61,5 (7,0) | 124 | 69,0 [61,7-76,2] | 106 | 57,8 [50,2-65,4] | 14 | 9,3 [4,3-14,2] |
Depressione | 85 | 4,7 | 59,1 (6,6) | 58 | 66,1 [55,3-77,0] | 36 | 46,5 [35,4-57,5] | 17 | 14,6 [8,3-21,0] |
Diabetes | 157 | 7,6 | 62,7 (7,4) | 91 | 59,7 [51,4-67,9] | 64 | 42,1 [33,8-50,4] | 20 | 14,1 [8,1-20,0] |
Dyslipidemiae | 234 | 11,8 | 63,2 (6,9) | 179 | 77,9 [72,0-83,8] | 143 | 62,7 [55,9-69,5] | 33 | 14,1 [9,2-18,9] |
Hypertensione | 369 | 18,8 | 62,0 (7,1) | 279 | 76,2 [71,7-80,9] | 216 | 59,2 [54,0-64,5] | 55 | 15,2 [11,4-19,0] |
Obesity | 319 | 15,3 | 61,0 (6,9) | 212 | 67,2 [61,8-72,6] | 167 | 53,9 [48,3-59,6] | 38 | 11,3 [7,8-14,8] |
Osteoarthritis | 707 | 35,8 | 62,4 (7,1) | 539 | 75,9 [72,4-79,3] | 410 | 57,3 [53,4-61,1] | 108 | 15,8 [12,9-18,7] |
Thyroid disorders | 253 | 12,5 | 62,0 (7,2) | 194 | 76,0 [70,4-81,7] | 140 | 53,6 [47,2-60,1] | 45 | 19,3 [14,1-24,4] |
Cervical cancer screening (Tables 1 and 3)
Models adjusted for | |||||||
---|---|---|---|---|---|---|---|
Age | Age and sociodemographic characteristicsb | Age and socioeconomic positionc | Age and health behavioursd | Age and healthcare accesse | Age and healthcare usef | Fully-adjustedg | |
OR [95 % CI] | |||||||
OR [95 % CI] | |||||||
OR [95 % CI] | OR [95 % CI] | ||||||
OR [95 % CI] | OR [95 % CI] | ||||||
OR [95 % CI] | |||||||
Inflammatory systemic diseaseh | 0.82 [0.53-1.29] | 0,78 [0,49-1,25] | 0,82 [0,50-1,35] | 0,81 [0,51-1,27] | 0,83 [0,52-1,33] | 0.88 [0.55-1.42] | 0,82 [0,48-1,39] |
Canceri | 1.53 [0.94-2.51] | 1,54 [0,95-2,51] | 1,76 [1,04-2,98] | 1,63 [1,00-2,68] | 2,00 [1,20-3,34] | 1.38 [0.82-2.32] | 1,73 [0,98-3,05] |
Cardiovascular diseases | 0.77 [0.47-1.25] | 0,81 [0,50-1,34] | 0,93 [0,57-1,52] | 0,81 [0,49-1,34] | 0,91 [0,54-1,51] | 0.84 [0.50-1.41] | 1,07 [0,61-1,86] |
Chronic respiratory diseases | 0.65 [0.49-0.85] | 0,71 [0,54-0,93] | 0,79 [0,60-1,05] | 0,67 [0,51-0,87] | 0,72 [0,54-0,96] | 0.64 [0.48-0.85] | 0,82 [0,60-1,13] |
Depressionj | 1.11 [0.75-1.65] | 0,27 [0,85-1,89] | 1,35 [0,90-2,03] | 1,16 [0,79-1,72] | 1,27 [0,84-1,91] | 1.05 [0.68-1.62] | 1,33 [0,84-2,09] |
Diabetes | 0.49 [0.33-0.72] | 0,53 [0,35-0,78] | 0,72 [0,48-1,09] | 0,50 [0,34-0,74] | 0,56 [0,36-0,85] | 0.53 [0.34-0.83] | 0,71 [0,44-1,15] |
Dyslipidemiaj | 0.98 [0.68-1.43] | 1,01 [0,70-1,47] | 1,08 [0,74-1,57] | 0,95 [0,66-1,39] | 1,04 [0,71-1,51] | 0.73 [0.49-1.11] | 0,79 [0,53-1,19] |
Hypertensionj | 0.89 [0.68-1.16] | 0,91 [0,69-1,20] | 0,95 [0,72-1,26] | 0,87 [0,66-1,14] | 0,92 [0,70-1,21] | 0.86 [0.64-1.15] | 0,92 [0,68-1,25] |
Obesity | 0.52 [0.43-0.65] | 0,56 [0,45-0,69] | 0,66 [0,53-0,83] | 0,52 [0,42-0,65] | 0,58 [0,46-0,72] | 0.61 [0.48-0.76] | 0,73 [0,57-0,93] |
Osteoarthritis | 0.91 [0.74-1.12] | 0,95 [0,77-1,17] | 1,06 [0,86-1,32] | 0,90 [0,73-1,10] | 0,97 [0,78-1,19] | 0.85 [0.68-1.06] | 0,96 [0,76-1,21] |
Thyroid disorders | 1.12 [0.85-1.49] | 1,12 [0,85-1,48] | 1,14 [0,85-1,53] | 1,11 [0,84-1,48] | 1,12 [0,84-1,48] | 1.03 [0.76-1.39] | 1,04 [0,76-1,42] |
Breast cancer screening (Tables 2, 4 and 5)
Models adjusted for | |||||||
---|---|---|---|---|---|---|---|
Age | Age and sociodemographic characteristicsb | Age and socioeconomic positionc | Age and health behavioursd | Age and healthcare accesse | Age and healthcare usef | Fully-adjustedg | |
OR [95 % CI] | |||||||
OR [95 % CI] | |||||||
OR [95 % CI] | OR [95 % CI] | ||||||
OR [95 % CI] | OR [95 % CI] | ||||||
OR [95 % CI] | |||||||
Inflammatory systemic diseaseh | 1.29 [0.73-2.28] | 1,27 [0,72-2,24] | 1,28 [0,73-2,27] | 1,24 [0,70-2,19] | 1,48 [0,83-2,65] | 1.46 [0.79-2.68] | 1,51 [0,82-2,78] |
Canceri | 0.91 [0.51-1.60] | 0,94 [0,53-1,66] | 0,97 [0,54-1,74] | 0,92 [0,52-1,63] | 1,17 [0,64-2,16] | 0.85 [0.48-1.51] | 1,10 [0,58-2,06] |
Cardiovascular diseases | 0.93 [0.57-1.51] | 0,93 [0,57-1,52] | 1,08 [0,65-1,78] | 0,97 [0,60-1,58] | 1,19 [0,72-1,97] | 0.90 [0.55-1.47] | 1,22 [0,72-2,05] |
Chronic respiratory diseases | 0.79 [0.54-1.14] | 0,81 [0,56-1,17] | 0,94 [0,65-1,36] | 0,81 [0,56-1,17] | 0,91 [0,62-1,32] | 0.79 [0.54-1.15] | 0,96 [0,64-1,42] |
Depressionj | 0.73 [0.44-1.20] | 0,77 [0,46-1,29] | 0,88 [0,54-1,44] | 0,74 [0,45-1,22] | 0,89 [0,53-1,48] | 0.67 [0.39-1.15] | 0,84 [0,48-1,45] |
Diabetes | 0.46 [0.32-0.65] | 0,48 [0,33-0,68] | 0,52 [0,36-0,74] | 0,44 [0,31-0,63] | 0,53 [0,35-0,79] | 0.48 [0.33-0.70] | 0,55 [0,36-0,83] |
Dyslipidemiaj | 1.17 [0.83-1.64] | 1,20 [0,86-1,69] | 1,25 [0,89-1,77] | 1,16 [0,82-1,64] | 1,21 [0,86-1,71] | 1.05 [0.73-1.49] | 1,13 [0,78-1,62] |
Hypertensionj | 1.06 [0.80-1.39] | 1,07 [0,81-1,41] | 1,10 [0,83-1,46] | 1,02 [0,77-1,36] | 1,09 [0,82-1,45] | 1.01 [0.76-1.35] | 1,03 [0,76-1,39] |
Obesity | 0.61 [0.46-0.80] | 0,62 [0,47-0,81] | 0,69 [0,52-0,92] | 0,59 [0,45-0,78] | 0,65 [0,49-0,86] | 0.64 [0.48-0.86] | 0,71 [0,52-0,96] |
Osteoarthritis | 1.13 [0.90-1.42] | 1,15 [0,92-1,45] | 1,21 [0,96-1,54] | 1,12 [0,89-1,41] | 1,17 [0,93-1,47] | 1.09 [0.86-1.38] | 1,16 [0,91-1,48] |
Thyroid disorders | 1.13 [0.81-1.57] | 1,11 [0,80-1,55] | 1,04 [0,75-1,45] | 1,14 [0,82-1,58] | 1,19 [0,85-1,67] | 0.99 [0.71-1.40] | 1,00 [0,70-1,41] |
No screening | Organized screening | Opportunistic screening | Wald testb (p) | |
---|---|---|---|---|
OR [95 % CI] | OR [95 % CI] | |||
Chronic Respiratory disease | ||||
Age-adjusted model | 1 | 0,92 [0,63-1,34] | 0,42 [0,22-0,81] | 0,01 |
Age and socioeconomic position-adjusted modelc | 1 | 1,08 [0,74-1,57] | 0,53 [0,27-1,01] | 0,02 |
Fully-adjusted modeld | 1 | 1,11 [0,74-1,66] | 0,54 [0,27-1,11] | 0,03 |
Diabetes | ||||
Age-adjusted model | 1 | 0,45 [0,30-0,65] | 0,47 [0,27-0,81] | 0,85 |
Age and socioeconomic position-adjusted modelc | 1 | 0,49 [0,34-0,73] | 0,60 [0,34-1,05] | 0,51 |
Fully-adjusted modeld | 1 | 0,50 [0,32-0,79] | 0,71 [0,37-1,36] | 0,25 |
Obesity | ||||
Age-adjusted model | 1 | 0,68 [0,51-0,91] | 0,42 [0,27-0,63] | 0,01 |
Age and socioeconomic position-adjusted modelc | 1 | 0,77 [0,57-1,04] | 0,51 [0,33-0,78] | 0,04 |
Fully-adjusted modeld | 1 | 0,78 [0,57-1,08] | 0,54 [0,34-0,86] | 0,08 |